---
$id: https://graph.org.ai/products/commodity/51182035
$type: Product
source: UNSPSC
code: "51182035"
title: "Nilutamide"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nilutamide

**UNSPSC Code**: 51182035
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C12H10F3N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51G6I8B902, chemically known as 5,5-dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin but generally known as nilutamide, which bears US NIH Compound Identifier 4493. European Medicines Agency schedules Nilutamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09291MIG. The term NILUTAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules nilutamide in its Anatomical Therapeutic Chemical (ATC) Classification. NILUTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nilutamide under HS 29332100 and SITC 51572. As of Q4 2014, NILUTAMIDE remains the US FDA Preferred Term for this commodity. Nilutamide bears US NLM identifiers UMLS ID C0722107 and NCI Concept Code C1173. SMILES: CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C.

